DB2313 (hydrochloride) |
| Catalog No.GC91805 |
DB2313 is an inhibitor of the transcription factor PU.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
DB2313 is an inhibitor of the transcription factor PU.1 (IC50 = 14 nM).[1] Long-term exposure of DB2313 (300 nM) to Kit+/Sca-1+/Lin- hematopoietic stem progenitor cells (KSL-HSPCs) reduces colony formation. DB2313 (700 nM) decreases ovalbumin-induced reprogramming of isolated mouse neutrophils into antigen-presenting cells.[2] It decreases tumor growth, weight, and volume in a U87MG glioblastoma multiforme mouse xenograft model when administered at a dose of 10 mg/kg per day.[3]
References:
[1].Antony-Debré, I., Paul, A., Leite, J., et al.Pharmacological inhibition of the transcription factor PU.1 in leukemiaJ. Clin. Invest.127(12)4297-4313(2017).
[2].Mysore, V., Cullere, X., Mears, J., et al.FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunityNat. Commun.12(1)4791(2021).
[3].Zhang, S., Zhao, S., Qi, Y., et al.SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent mannerMol. Ther. Nucleic Acids27699-717(2022).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *